175 related articles for article (PubMed ID: 33194578)
1. Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study.
Song C; Yu D; Wang Y; Wang Q; Guo Z; Huang J; Li S; Hu W
Front Oncol; 2020; 10():515606. PubMed ID: 33194578
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors Analysis and Nomogram Construction of Dual Primary Lung Cancer: A Population Study.
Song CK; Guo ZX; Shen XY; Wang YJ; Wang QW; Yu DH; Chen C; Liu XP; Huang JY; Li S; Hu W
Biomed Res Int; 2020; 2020():7206591. PubMed ID: 32149127
[TBL] [Abstract][Full Text] [Related]
3. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Prognostic Model to Predict Overall Survival for Lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter Lung Cancer Database.
Wang Z; Hu F; Chang R; Yu X; Xu C; Liu Y; Wang R; Chen H; Liu S; Xia D; Chen Y; Ge X; Zhou T; Zhang S; Pang H; Fang X; Zhang Y; Li J; Hu K; Cai Y
Technol Cancer Res Treat; 2022; 21():15330338221133222. PubMed ID: 36412085
[No Abstract] [Full Text] [Related]
5. Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.
Li Y; Chen T; Fu B; Luo Y; Chen L
Front Oncol; 2023; 13():1164401. PubMed ID: 37397381
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database.
Zhang J; Zhang J
BMC Pulm Med; 2023 Oct; 23(1):413. PubMed ID: 37899470
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.
Wang Q; Wang Y; Wang X; Nakamura Y; Hydbring P; Yamauchi Y; Zhao X; Cao M
Transl Lung Cancer Res; 2022 Aug; 11(8):1678-1691. PubMed ID: 36090634
[TBL] [Abstract][Full Text] [Related]
9. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
Front Public Health; 2022; 10():946299. PubMed ID: 36159305
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel nomogram model for predicting the survival of patients with T2-4a, N0-x, M0 bladder cancer: a retrospective cohort study.
Xia Y; Liu X; Ma B; Huang T; Xu D; Zhao C
Am J Clin Exp Urol; 2023; 11(6):500-515. PubMed ID: 38148935
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis and clinical characteristics of dual primary lung cancer: a population study based on surveillance, epidemiology, and end results (SEER) database.
Wang G; Zeng Y; Zheng H; Zhao X; Wang Y; Shen H; Du J
Gen Thorac Cardiovasc Surg; 2022 Aug; 70(8):740-749. PubMed ID: 35316521
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
[TBL] [Abstract][Full Text] [Related]
13. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis.
Xiong Y; Gu F; Cui J; Liu Y; Sun M; Gu X; Zhong L; Zhang K; Liu L
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15039-15053. PubMed ID: 37612389
[TBL] [Abstract][Full Text] [Related]
15. Development and external validation of a novel prognostic nomogram for overall survival in prostate cancer patients with bone metastatic: a retrospective study of the SEER-based and a single Chinese center.
Zhang H; Jiang X; Jiao L; Sui M
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12647-12658. PubMed ID: 37450026
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database.
Zhang S; Xiao X; Qin X; Xia H
Transl Cancer Res; 2023 Oct; 12(10):2742-2753. PubMed ID: 37969392
[TBL] [Abstract][Full Text] [Related]
17. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort.
Li Y; Liu J; Xu Z; Shang J; Wu S; Zhang M; Liu Y
Front Oncol; 2023; 13():1231302. PubMed ID: 37954073
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis.
Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G
Front Oncol; 2022; 12():921365. PubMed ID: 36465408
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer.
Xu C; Pei D; Liu Y; Guo J; Liu N; Wang Q; Yu Y; Kang Z
Front Oncol; 2023; 13():918324. PubMed ID: 37260974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
